TY - JOUR
T1 - Chimeric Mouse With Humanized Liver Is an Appropriate Animal Model to Investigate Mode of Action for Porphyria-Mediated Hepatocytotoxicity
AU - Eguchi, Ayumi
AU - Fukunaga, Satoki
AU - Ogata, Keiko
AU - Kushida, Masahiko
AU - Asano, Hiroyuki
AU - Cohen, Samuel M.
AU - Sukata, Tokuo
N1 - Funding Information:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Sumitomo Chemical Company, Ltd.
Funding Information:
The authors are grateful to Dr Chise Tateno and other contributors from PhoenixBio Co, Ltd for scientific advice and assistance. The authors would like to extend their thanks to Hiroko Kikumoto, Keiko Maeda, Maki Yamaguchi, and Keiko Tanaka for technical support and Kaori Miyata for research advice. The authors also thank the other contributors to this research project from Sumitomo Chemical Company, Ltd, Valent U.S.A. LLC, and Sumika Technoservice Corporation. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Sumitomo Chemical Company, Ltd.
Publisher Copyright:
© The Author(s) 2021.
PY - 2021/10
Y1 - 2021/10
N2 - Porphyrinogenic compounds are known to induce porphyria-mediated hepatocellular injury and subsequent regenerative proliferation in rodents, ultimately leading to hepatocellular tumor induction. However, an appropriate in vivo experimental model to evaluate an effect of porphyrinogenic compounds on human liver has not been fully established. Recently, the chimeric mouse with humanized liver (PXB mice) became widely used as a humanized model in which human hepatocytes are transplanted. In the present study, we examined the utility of PXB mice as an in vivo experimental model to evaluate the key events of the porphyria-mediated cytotoxicity mode of action (MOA) in humans. The treatment of PXB mice with 5-aminolevulinic acid, a representative porphyrinogenic compound, for 28 days caused protoporphyrin IX accumulation, followed by hepatocyte necrosis, increased mitosis, and an increase in replicative DNA synthesis in human hepatocytes, indicative of cellular injury and regenerative proliferation, similar to findings in patients with porphyria or experimental porphyria models and corresponding to the key events of the MOA for porphyria-mediated hepatocellular carcinogenesis. We conclude that the PXB mouse is a useful model to evaluate the key events of the porphyria-mediated cytotoxicity MOA in humans and suggest the utility of PXB mice for clarifying the human relevancy of findings in mice.
AB - Porphyrinogenic compounds are known to induce porphyria-mediated hepatocellular injury and subsequent regenerative proliferation in rodents, ultimately leading to hepatocellular tumor induction. However, an appropriate in vivo experimental model to evaluate an effect of porphyrinogenic compounds on human liver has not been fully established. Recently, the chimeric mouse with humanized liver (PXB mice) became widely used as a humanized model in which human hepatocytes are transplanted. In the present study, we examined the utility of PXB mice as an in vivo experimental model to evaluate the key events of the porphyria-mediated cytotoxicity mode of action (MOA) in humans. The treatment of PXB mice with 5-aminolevulinic acid, a representative porphyrinogenic compound, for 28 days caused protoporphyrin IX accumulation, followed by hepatocyte necrosis, increased mitosis, and an increase in replicative DNA synthesis in human hepatocytes, indicative of cellular injury and regenerative proliferation, similar to findings in patients with porphyria or experimental porphyria models and corresponding to the key events of the MOA for porphyria-mediated hepatocellular carcinogenesis. We conclude that the PXB mouse is a useful model to evaluate the key events of the porphyria-mediated cytotoxicity MOA in humans and suggest the utility of PXB mice for clarifying the human relevancy of findings in mice.
KW - chemical-induced porphyria
KW - chimeric mouse with humanized liver
KW - porphyria-mediated cytotoxicity MOA
UR - http://www.scopus.com/inward/record.url?scp=85109777173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109777173&partnerID=8YFLogxK
U2 - 10.1177/01926233211027474
DO - 10.1177/01926233211027474
M3 - Article
C2 - 34238059
AN - SCOPUS:85109777173
VL - 49
SP - 1243
EP - 1254
JO - Toxicologic Pathology
JF - Toxicologic Pathology
SN - 0192-6233
IS - 7
ER -